Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function
Status:
Unknown status
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
To compare and analysis pharmacokinetics of PEX 168 in patients with renal insufficiency or
normal renal function who were administrated subcutaneously single dose PEX168.To evaluate
dose adjustment of PEX168 administered in patients with renal insufficiency and provide a
scientific basis in patients with renal insufficiency of rational drug use.